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Background: Patients with chronic heart failure (CHF) suffer from exercise intolerance due to impaired central
hemodynamics and subsequent alterations in peripheral skeletal muscle function and structure. The relative
contribution of central versus peripheral factors in the reduced exercise capacity is still subject of debate. The
main purpose was to investigate heterogeneity in the nature of exercise intolerance by evaluating individual
cardiac output (Q) patterns. The secondary purpose was to evaluate whether patient and disease characteristics
were associated with a central hemodynamic exercise limitation.
Methods: Sixty-four stable CHF patients performed a symptom limited incremental exercise test with respiratory
gas analysis and simultaneous assessment of Q, using a radial artery pulse contour analysis method. A central
hemodynamic exercise limitation was defined as a plateau or decline in Q from 90 to 100 % of exercise duration.
Results: Data from 61 patients were analyzed. A central hemodynamic exercise limitation was observed in 21
patients (34 %). In these patients, a higher occurrence of a plateau/decrease in oxygen uptake (VO2) (52 % vs 23 %,
p = 0.02), stroke volume (SV) (100 % vs. 75 %, p = 0.01) and chronotropic incompetence (31 % vs. 2.5 %, p = 0.01) was
observed, while presence of a left bundle branch block (LBBB) occurred significantly less (19 % vs 48 %, p = 0.03) There
was no difference in disease characteristics such as etiology, duration, NYHA class, mitral regurgitation or ischemia.
Conclusions: The study revealed considerable heterogeneity in the nature of exercise limitations between moderately
impaired CHF patients. In one third of the study population a plateau or decrease in Q towards peak exercise was
demonstrated, which is indicative of a central hemodynamic exercise limitation. A central hemodynamic exercise
limitation was associated with an impairment to augment stroke volume and heart rate.
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Chronic heart failure (CHF) is a clinical syndrome resulting
from inadequate tissue oxygenation due to impaired
cardiac function. Although it is well established that
patients with CHF suffer from exercise intolerance,
the underlying pathophysiological mechanisms remain
controversial. From a theoretical point of view, reduced* Correspondence: r.spee@mmc.nl
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abnormalities in the lungs, impaired central hemodynamics
or peripheral derangements such as a reduced skeletal
muscle capillarization or metabolic capacity. Whereas it is
generally accepted that pulmonary O2 diffusion does not
limit exercise capacity in compensated CHF patients, the
role of central and peripheral factors is still under debate
[1]. Previous studies showed associations between maximal
exercise capacity and central hemodynamics [2, 3], whereas
other studies revealed a relation between exercise capacity
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exercise limitations differs between CHF patients. In fact,
results from an animal study demonstrated that the pri-
mary response of microvascular oxygen pressure in the
muscle was speeded in rats with moderate left ventricular
(LV) dysfunction, while in rats with severe LV dysfunction,
this response was significantly slowed [6]. These results
suggest that the dynamic balance between oxygen delivery
and utilization in the muscle is dependent of the severity of
cardiac dysfunction, indicating physiological heterogeneity.
Although additional physiological insight is needed in
humans, some clinical studies suggested heterogeneity in
exercise limitations. As such, CHF patients with a severe
central hemodynamic limitation did not benefit from
exercise training [7], but may benefit most from a
heart transplantation [8]. Characterization of exercise
limitations in individual CHF patients and more know-
ledge on disease characteristics associated with the nature
of these limitations may lead to a more tailored thera-
peutic strategy in CHF patients. An approach that can be
used to characterize exercise limitations is to examine the
pattern of the cardiac output (Q) response to symptom-
limited exercise, with a failure to augment or a decrease in
cardiac output towards peak exercise being indicative of a
central hemodynamic exercise limitation [9]. Although
previous studies investigated the cardiac output response
to exercise with respect to prognosis [10, 11], no studies
used cardiac output patterns during incremental exercise
to characterize exercise limitations in CHF patients.
The primary goal of this study was to investigate the
nature of the limitation of maximal exercise capacity in
CHF patients by evaluation of cardiac output patterns.
Furthermore we evaluated whether patient and disease
characteristics are associated with a central hemodynamic
exercise limitation.
Methods
The present study was designed as a prospective co-
hort study. All tests were conducted at the Department of
Cardiology of the Máxima Medical Centre, the Netherlands.
The research protocol was approved by the medical ethics
committee of the Máxima Medical Centre. The study com-
plies with the Declaration of Helsinki. All patients provided
written and signed informed consent, prior to the study.
Population
All consecutive symptomatic CHF patients visiting the
outpatient clinic of cardiology were considered for
participation in the study. Additional inclusion criteria
were: CHF secondary to ischemic or dilated cardiomyop-
athy, New York Heart Association functional class II-III,
left ventricular ejection fraction ≤ 40 % and optimized
medical treatment. Exclusion criteria were: recent myo-
cardial infarction, unstable angina (less than 3 monthsprior to inclusion), hemodynamically significant aortic valve
disease, participation in a training program (≥2/week) in
the last year, significant chronic obstructive pulmonary
disease (FEV1/FVC < 60 %) and orthopedic or neuromus-
cular conditions limiting the ability to perform exercise.
Exercise testing
All patients performed a symptom-limited incremental
exercise test on an electromagnetically braked cycle
ergometer in an upright position (Corrival, Lode,
Groningen, The Netherlands), using an individualized
ramp protocol with a duration of 8 to 12 min. The
test ended when a patient was not able to maintain
the required pedaling frequency of 70 per minute. A
12-lead electrocardiogram was registered continuously.
Ventilatory parameters were measured breath-by-breath
(ZAN 680 USB, ZAN Messgeräte, Oberthulba, Germany).
Volume and gas analyzers were calibrated before each test.
Assessment of central hemodynamics
Assessment of central hemodynamics was performed by
a radial artery pulse contour analysis method (LiDCO,
LiDCO Ltd, London, UK). This technique provides beat-
to-beat changes in central hemodynamics, by calculating
nominal stroke volume (SV) from a pressure-volume
transform of the radial artery pressure waveform [12]. In
order to convert nominal SV to absolute SV, the system has
to be calibrated at rest for each subject by an independent
method. We used echocardiography or lithium dilution for
this purpose [13, 14]. Before the exercise test, a 20-gauge
arterial catheter was inserted into the radial artery. The
radial artery catheter was connected to the LiDCO plus
monitor. Subsequently, the calibration procedure to
determine resting Q was performed in the supine
position. Thereafter patients were positioned upright
on the cycle ergometer and the exercise protocol was
started. Patients were instructed to keep the measured
arm on the handlebar of the ergometer in the same
position to keep an optimal arterial waveform. Previous
studies showed that LiDCO is a reproducible and accurate
method for assessment of cardiac output (Q) under a
variety of physiological conditions [15, 16]. Moreover, in a
study using the Fick method as a reference, we showed
that this technique is highly accurate for continuous
assessment of Q during incremental symptom-limited
exercise testing in CHF patients [13].
Data analysis
Breath-to-breath data of oxygen uptake and beat-to-beat
data of central hemodynamics were filtered for outliers
using Python (Python 2.7, Python Software Foundation).
Outliers were defined as values deviating more than
three standard deviations from a calculated moving
average [17]. All data were time aligned using manual
Table 1 Hemodynamic and gas exchange variables at rest and
during exercise (n =61)
Baseline Peak exercise
VO2 (mL min
−1 kg−1) 4.3 ± 1.3 19.0 ± 5.9
HR (beats min−1) 80 ± 17 124 ± 26
SV (mL) 62 ± 14 87 ± 23
Q (L min−1) 4.9 ± 1.5 10.9 ± 4.1
VO2 oxygen uptake, HR heart rate, SV stroke volume, Q Cardiac Output
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a central moving average filter with a window of 11
data points. In order to compare gas exchange and
central hemodynamic variables during exercise between
CHF patients, data were expressed as a percentage of total
exercise time. Baseline values were calculated as the mean
of the first 60 s of the unloaded phase prior to the start of
loaded exercise. Peak values were defined as the average
values during the final 20 s of the test. We characterized
exercise limitations by using the pattern of the cardiac out-
put response to maximal exercise. A failure to increase or
a decrease in cardiac output towards the end of exercise
was considered to be indicative of a central hemodynamic
exercise limitation. A central hemodynamic exercise limita-
tion was defined as a plateau or decline in Q from 90 to
100 % of exercise time. Chronotropic incompetence was
defined as a peak HR below 80 % of the age-predicted
heart rate, using the Brawner formula [18].
Statistical analysis
Data were analyzed using SPSS 19.0.0 statistical software
(SPSS Inc, Chicago, IL, USA). Continuous variables were
tested for normality and presented as mean or mean ± SD.
Between-group differences of continuous variables were
evaluated by an independent t-test. Categorical variables
are presented as absolute and relative frequencies. The χ2
test was used to evaluate differences between categor-
ical data. Differences were presented as χ2 value with
concomitant degree of freedom (df) Relations between
variables were assessed by Pearson’s correlation coefficient
(r). For all statistical comparisons, the level of significance
was set at p < 0.05.
Results
All 64 patients completed the combined hemodynamic
and cardiopulmonary exercise test, without adverse events.
Central hemodynamic data from 3 patients were excluded
because of insufficient data quality due to excessive
damping of the arterial pressure waveform during exercise.
In total, data of 61 patients were analyzed.
The majority of the study population were males (84 %);
the mean age was 63 ± 9 years. At the time of inclusion,
patients were diagnosed with CHF for a mean duration of
45 ± 51 months. Ninety-eight percent used ACE inhibitors
or an angiotensin II receptor blocker, 93 % used beta
blockers. Thirty-four patients had an ischemic cardio-
myopathy (due to one or more myocardial infarc-
tions > 3 months prior to inclusion), 2 patients showed
signs of myocardial ischemia during evaluation by
non-invasive stress testing (i.e. positive exercise test or
myocardial perfusion scintigraphy) or coronary angiog-
raphy, which required percutaneous coronary intervention
(PCI). Six patients had severe mitral regurgitation at
resting echocardiography. Twenty-three patients had LeftBundle Branch Block (LBBB) and seven patients had atrial
fibrillation.
Central hemodynamic and gas exchange variables at rest
and maximal exercise
Gas exchange and hemodynamic variables at rest and
peak exercise are presented in Table 1. The mean peak
workload was 125 ± 49 Watt. The mean peak VO2 was
19.0 ± 5.9 mL min−1 kg−1 and VO2 at the ventilatory
threshold was 11.9 ± 2.9 mL min−1 kg−1, corresponding
to 63 % of peak VO2. Mean peak RER was 1.07 ± 0.1.
There was a significant correlation between peak VO2
and peak Q (r =0.64, p < 0.001).
Patterns of central hemodynamic variables during
incremental exercise
Fig. 1a and b show respectively, exercise-induced
changes of VO2 and Q at a group level. Both VO2 and Q
show a continuous increase throughout the exercise test.
Looking at patterns of Q in individual patients, 21 patients
(34 %) showed a plateau or decrease in Q during the final
10 % of exercise duration (Fig. 2b), while 40 patients
(66 %) showed a continuous increase in Q (Fig. 2a).
Table 2 shows a comparison of patient and disease
characteristics between patients with a plateau/decrease
in Q and patients with a continuous increase in Q.
There was no significant between-group difference in
beta blocker use (χ2 value 0.17, df = 1, p =0.68). Peak
VO2, peak Q and SV did not differ between both groups.
In 11 of the 21 patients with a plateau/decrease in Q
(52 %), a plateau/decrease in VO2 was also observed.
Nine out of 40 patients (23 %) with a continuous
increase in Q, showed a plateau/decrease in VO2 (χ2 value
5.58, df = 1, p = 0.02 for between group comparison). In
patients with a plateau/decrease in Q, all patients showed
a plateau/decrease in SV as opposed to 30 patients (75 %)
in the group with a continuous increase in Q (χ2 value
6.28, df = 1, p = 0.01 for between group comparison)
(Table 2). Chronotropic incompetence was observed
more often in patients with a plateau or decrease in
Q (31 % versus 2.5 %, χ2 value 7.05, df = 1, p < 0.01).
There was a higher occurrence of a plateau/decrease
in SV in patients with chronotropic incompetence
(83 % versus 52 %, p =0.047), but no significant difference
Fig. 1 a: Mean oxygen uptake (VO2) and b: mean cardiac output (Q) response during a symptom limited exercise test. Error bars represent one
standard deviation above and below the mean
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pic incompetence (74 ± 22 versus 89 ± 22 mL respectively,
p =0.29). Left Bundle Branch Block was observed signifi-
cantly less in patients with a Q plateau/decrease (χ2 value
4.84, df = 1, p = 0.03). No differences between groups were
observed for patients with severe mitral regurgitation at
rest or myocardial ischemia.Discussion
This is the first study in patients with CHF to char-
acterize physiological limitations at maximal exercise
by assessment of the pattern of Q during incremental
exercise. In one third of the study population we
demonstrated a failure to augment Q towards the end of
the exercise test, (Fig. 2b) while a continuous increase was
Fig. 2 a: Individual cardiac output (Q) responses with an continuous increase during exercise (n =40) and b: individual cardiac output (Q)
responses with a plateau or decrease during the final 10 % of exercise during a symptom limited exercise test (n =21)
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indicate that physiological heterogeneity in exercise
limitations exists among CHF patients.
As the nature of the exercise limitation may be an
important determinant for the selection of patients
for specific treatments, (e.g. exercise training, heart
transplantation, cardiac resynchronization therapy) these
observations may be relevant for clinical practice.Although we demonstrated a continuous increase in Q
throughout the incremental symptom-limited exercise test
at group level, we observed a wide inter-individual
variation in Q patterns. These observations are different
from earlier findings in healthy individuals, showing a
continuous increase in Q in all subjects [19]. Whereas in-
dividual Q patterns during symptom-limited exercise were
not used previously to characterize exercise limitations in
Table 2 Characteristics comparison between subjects with increase in Q or plateau/decrease in Q (n = 61)
Increase in Q (n = 40) Plateau/decrease in Q (n = 21) χ2 value (df) p-value
Age (years) 63 ± 10 64 ± 9 n.a. NS
Gender male/female (%) 33 (83)/7 (17) 18 (86)/3 (14) 0.10 (1) NS
Etiology ICM/DCM (%) 21 (53)/19 (47) 13 (62)/8 (38) 0.49 (1) NS
Duration CHF (months) 45 ± 50 46 ± 54 n.a. NS
Beta blocker (%) 93 95 0.17 (1) NS
NYHA class II/III (%) 24 (60)/16 (40) 11 (52)/10 (48) 0.33 (2) NS
LVEF (%) 31 ± 8 33 ± 10 n.a. NS
Peak VO2 (mL min
−1 kg−1) 19.4 ± 6.0 18.2 ± 5.9 n.a. NS
Peak Q (L min−1) 11.3 ± 3.6 10.2 ± 5.0 n.a. NS
Peak SV (mL) 90 ± 24 83 ± 22 n.a. NS
Plateau/decrease in VO2 9 (23 %) 11 (52 %) 5.58 (1) 0.02
Plateau/decrease in SV 30 (75 %) 21 (100 %) 6.28 (1) 0.01
Rest HR (beats min−1) 81 ± 16 77 ± 18 n.a. NS
Peak HR (beats min−1) 126 ± 20 121 ± 35 n.a. NS
Chronotropic incompetence 1 (2.5 %) 5 (31 %) 7.05 (1) 0.01
Rhythm (SR, Afib, paced) (%) 35 (88)/2 (5)/3 (7) 15 (71)/5 (24)/1 (5) 4.85 (2) NS
LBBB 19 (48 %) 4 (19 %) 4.84 (1) 0.03
Severe mitral regurgitation 3 (7.5 %) 3 (14 %) 0.72 (1) NS
Myocardial ischemia 2 (5 %) 0 (0 %) 1.09 (2) NS
χ2 value, chi-squared value for categorical values, df degree of freedom,n.a. not applicable, ICM ischemic cardiomyopathy, DCM dilated cardiomyopathy, CHF
chronic heart failure, NYHA New York Heart Association, LVEF left ventricular ejection fraction, VO2 oxygen uptake, Q cardiac output, SV stroke volume, HR heart
rate, SR sinus rhythm, Afib atrial fibrillation, LBBB left bundle branch block, . NS non significant
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central hemodynamic responses to exercise in CHF
populations by relating Q to VO2. In these studies,
32-55 % of CHF patients were classified as having a
central hemodynamic limitation of maximal exercise
capacity [7, 8], which is in line with our study. Studies
using other methods to investigate determinants of
maximal exercise capacity in CHF patients demonstrated
strong relations between maximal exercise capacity and
both skeletal muscle function, e.g. reduced skeletal muscle
metabolic capacity or peripheral O2 transport [4, 5, 20], as
well as central hemodynamics [2, 3]. However, these results
did not allow to draw conclusions on the relative contribu-
tions of central and peripheral factors to impaired maximal
exercise capacity, nor on the presence of physiological
heterogeneity in CHF patients. Studies investigating the
influence of peripheral and central factors on exercise
capacity simultaneously are scarce and yielded conflicting
results. Whereas some of these studies indicate that intrin-
sic differences in skeletal muscle metabolism are the main
determinants of a reduced exercise capacity [21, 22], other
studies show that a reduced O2 delivery to exercising mus-
cles is the primary limiting factor [23, 24]. Possible expla-
nations for this discrepancy may be the variety in exercise
protocols that were used but also physiological heterogen-
eity in exercise limitations in these study populations.One third of our population showed a central hemo-
dynamic limitation of maximal exercise capacity. This
limitation was associated with a more frequent occurrence
of a plateau/ decrease in VO2. Furthermore a central
exercise limitation was associated both with a higher
occurrence of a plateau/decrease in SV and a higher occur-
rence of chronotropic incompetence. From a physiological
point of view, the inability to augment forward SV may be
caused by impaired global left atrial [25] or ventricular
contractile reserve, regional contractility disorders due to
ischemia, valvular disorders such as mitral regurgitation
and dyssynchrony. As severe mitral regurgitation at rest
and ischemia were not identified as determinants of a
central exercise limitation, an impaired global contractile
reserve is likely to be the most important determinant of
impaired SV augmentation in our population. In addition
to a failure to augment SV, a central exercise limitation
was also associated with a higher occurrence of chronotro-
pic incompetence . In theory, this observation may be
caused by neurohormonal dysregulation or the use of beta
blockers. Previous studies showed that the lower peak
heart rate during long-term administration of beta blockers
is associated with a higher peak SV [26, 27]. In contrast, in
our study population, patients with chronotropic incompe-
tence, had a higher occurrence of failure to augment
SV and a non-statistically significant lower peak SV. A
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relation between peak oxygen uptake and change in heart
rate, with no significant difference for patients with or
without beta blockers [28]. As 93 % patients in our study
used beta blockers and there was no difference in beta
blocker use in both groups, this could not explain the dif-
ference in occurrence of chronotropic incompetence.
Therefore, we postulate that chronotropic incompetence
based on neurohormonal dysregulation (i.e. an imbalance
between sympathic and parasympathic nerve activity)
can be a contributory factor limiting exercise capacity
in patients with a central exercise limitation. Our results
showed significantly less patients with LBBB in the
centrally limited group. This could be explained by
studies that provide evidence that left ventricular (i.e.
mechanical) dyssynchrony is irrespective of the QRS
duration. Moreover, it is suggested that dyssynchrony is a
dynamic condition and may worsen during exercise [29].
Characterization of exercise limitations may be benefi-
cial in clinical practice for a better understanding of the
causes of impairments in daily functioning. In addition,
this approach may contribute to a more tailored
therapeutic strategy in individual CHF patients. As
such, Wilson et al. showed that patients with a re-
duced cardiac output response to exercise benefit less
from a moderate intensity exercise training program
than patients with a normal cardiac output response
[7]. Yet, other studies showed that patients with a
more pronounced central exercise limitation may
benefit more from interventions aimed at improving
central hemodynamics such as heart transplantation
[8] and cardiac resynchronization therapy [30]. Whether
the approach used in the present study will contribute to
a better prediction of treatment results in individual CHF
remains to be determined.
Before drawing conclusion from this study, several
limitations should be acknowledged. First, we used an
arbitrary method to classify exercise limitations. In fact,
some patients that were not classified as having a central
exercise limitation showed only small increases in Q
during the final part of exercise. Second, the limited
sample size did not permit to perform additional sub-
group analyses. For instance, due to the fact that
most patients were moderately impaired, we were un-
able to test the hypothesis, generated from animal
studies that patient with more severe left ventricular
dysfunction at rest have a more pronounced peripheral
limitation than those with moderate left ventricular
dysfunction [6]. Third, assessment of valvular disease
and dyssynchrony was performed by resting echocar-
diography. However, as both may worsen during
exercise [31], we cannot fully exclude that this factor
played a role in the failure to augment SV and Q towards
maximal exercise.Conclusion
This study revealed heterogeneity in exercise limitations
in CHF patients. In one third of the study population a
plateau or decrease in Q towards peak exercise was
demonstrated, which is indicative of a central exercise
limitation. Factors associated with a central exercise limita-
tion included a higher occurrence of a failure to augment
SV and chronotropic incompetence, suggesting that both
impaired contractile reserve and neurohormonal dysregu-
lation are determinants of reduced exercise capacity in
centrally limited patients. Future research should focus on
the clinical utility of characterizing exercise limitations to
predict treatment effects in CHF patients.
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